<i>Put the Vanc Down, Flip It and Reverse It</i>: Comparison of Vancomycin and Daptomycin Health Care Utilization and Cost in Outpatient Parenteral Antimicrobial Therapy-Reference-Cited by-同舟云学术

Put the Vanc Down, Flip It and Reverse It: Comparison of Vancomycin and Daptomycin Health Care Utilization and Cost in Outpatient Parenteral Antimicrobial Therapy

Published:2024-07-25 Issue:8 Volume:11 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Streifel Amber C¹^ORCID,Luis Katie²,Nakrani Monark¹,Yu Diana¹,Sikka Monica K²,Varley Cara D²³,Douglass Alyse²,Mayer Heather²,Young Kathleen²,Lewis James S¹

Affiliation:

1. Department of Pharmacy, Oregon Health & Science University , Portland, Oregon , USA

2. Division of Infectious Diseases, Department of Medicine, Oregon Health & Science University , Portland, Oregon , USA

3. Epidemiology Programs, School of Public Health, Oregon Health & Science University–Portland State University , Portland, Oregon , USA

Abstract

Abstract Vancomycin and daptomycin are frequently used in outpatient parenteral antimicrobial therapy (OPAT). We analyze health care utilization and cost to the health care system for vancomycin vs daptomycin in the outpatient setting and find that vancomycin results in significantly higher health care utilization and similar cost per course compared with daptomycin in OPAT.

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofae438/58653151/ofae438.pdf

Reference12 articles.

1. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service;Durojaiye;Int J Antimicrob Agents,2018

2. Patient satisfaction in an outpatient parenteral antimicrobial therapy (OPAT) unit practising predominantly self-administration of antibiotics with elastomeric pumps;Saillen;Eur J Clin Microbiol Infect Dis,2017

3. Rates of and risk factors for adverse drug events in outpatient parenteral antimicrobial therapy;Keller;Clin Infect Dis,2018

4. Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study;Huang;BMC Pharmacol Toxicol,2018

5. Vascular access complications during outpatient parenteral antimicrobial therapy at home: a retrospective cohort study;Shrestha;J Antimicrob Chemother,2016